Pioneer Pharma PLC

CIF-01445 · U76444AU2014PLC101445 · Hospitality · Micro Enterprise · Australia

Back
RM: Harper Davis
Credit Risk Manager: Michael Miller
Exposure: $1.29M
CBRB: Normal
Internal: Normal
Risk Score:25 · Low
Total Exposure
$1.29M
Prev: $1.28M1.1%
Utilization
33.9%
Prev: 39.8%5.9pp
Banking Relationships
1
Prev: 10.0
CBRB Rating
Normal
Prev: Normal
Internal Rating
Normal
Prev: Normal
Open Alerts
1
C 0
H 0
M 0
L 1

Exposure Trend Analysis · 24 Months

Funded · Non-Funded · Total

Utilization Trend · Reporting Bank vs Other Banks

Threshold 70%

Rating Migration Timeline

No rating changes in the last 24 months. Currently Normal.

Banking Relationship Trend · Number of Banks (CBRB)

Increase Decrease No Change

Alert History · 2

DateAlert TypeSeverityDescriptionStatusAssigned ToResolved
3/25/2026Rating DowngradeCriticalBorrower rating migrated from Normal to Normal.
Dismissed
James Smith
6/4/2026Exposure IncreaseLowSystem-wide exposure increased materially over the prior month.
Open
Christopher Lopez

AI Risk Score

25
/ 100
Low Risk
Low
0-30
Med
31-60
High
61-80
Crit
81-100

Risk Driver Analysis

CBRB Rating Migration+15
Industry Concentration+12
Utilization Level+8
Banking Relationship Growth+6
Exposure Growth Trend+5
Internal Rating Drift+5

AI Risk Commentary

AI
Customer exposure increased by 1.1% month-over-month, currently at $1.29M. Banking relationships moved from 1 to 1 banks per CBRB data. CBRB rating remained stable from Normal to Normal. Current utilization is 33.9%. Overall borrower risk is assessed as low.

Recommended Actions

Review Credit Facility Structure
High
Schedule Customer Meeting
Medium
Reassess Collateral Coverage
Medium
Escalate to Credit Committee
Low
Initiate Monthly Monitoring
Medium

Relationship Team

Relationship Manager
Harper Davis
harper.davis@bank.com
+1 555 0220
Portfolio: $2.09B
Credit Risk Manager
Michael Miller
michael.miller@bank.com
+1 555 0033
Portfolio: $2.26B
Business Head
Matthew Sanchez
matthew.sanchez@bank.com
+1 555 0099
Portfolio: $2.20B
MonthFundedNon-FundedTotalUtilizationBanksRating
2026-06$744.2K$547.0K$1.29M33.9%1Normal
2026-05$752.6K$524.3K$1.28M39.8%1Normal
2026-04$789.2K$547.9K$1.34M42.6%1Normal
2026-03$846.7K$496.9K$1.34M42.7%1Normal
2026-02$849.2K$420.5K$1.27M46.5%1Normal
2026-01$747.7K$508.4K$1.26M41.8%1Normal
2025-12$700.0K$551.7K$1.25M47.7%2Normal
2025-11$690.3K$571.4K$1.26M52.4%2Normal
2025-10$807.9K$458.3K$1.27M58.4%2Normal
2025-09$723.8K$566.5K$1.29M54.0%2Normal
2025-08$833.2K$404.1K$1.24M57.7%2Normal
2025-07$756.4K$443.3K$1.20M54.4%2Normal